# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012134
Filing Date
2024-08-14
Accepted
2024-08-14 07:02:59
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | plx-20240630x10q.htm iXBRL | 10-Q | 1072218
2 | EX-31.1 | plx-20240630xex31d1.htm | EX-31.1 | 12568
3 | EX-31.2 | plx-20240630xex31d2.htm | EX-31.2 | 12737
4 | EX-32.1 | plx-20240630xex32d1.htm | EX-32.1 | 6808
5 | EX-32.2 | plx-20240630xex32d2.htm | EX-32.2 | 6830
6 | GRAPHIC | plx-20240630x10q005.jpg | GRAPHIC | 113104
7 | GRAPHIC | plx-20240630x10q007.jpg | GRAPHIC | 100730
8 | GRAPHIC | plx-20240630x10q008.jpg | GRAPHIC | 61840
| Complete submission text file | 0001558370-24-012134.txt |  | 5000196

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | plx-20240630.xsd | EX-101.SCH | 32225
10 | EX-101.CAL | plx-20240630_cal.xml | EX-101.CAL | 39428
11 | EX-101.DEF | plx-20240630_def.xml | EX-101.DEF | 124586
12 | EX-101.LAB | plx-20240630_lab.xml | EX-101.LAB | 226532
13 | EX-101.PRE | plx-20240630_pre.xml | EX-101.PRE | 201153
58 | EXTRACTED XBRL INSTANCE DOCUMENT | plx-20240630x10q_htm.xml | XML | 564699

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 241204094
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)